The Precision Peptide Genetic Test has nothing to do with insurance and does not predict medication response
The Cliffs Notes version is this: Ive been dieting for as long as Ive been fat, and its never worked, just as science tells us it wont
Semaglutide is, in chronological order, the newest GLP-1 RA approved for the treatment of T2D
Intravenous (IV) Glutathione : Administered directly into the bloodstream, this method offers the highest bioavailability and immediate effects, often used in clinical settings
Most sermorelin research focuses on older adults with growth hormone deficiency, not younger patients seeking weight reduction
New research providing further support for obesity drugs December 18, 2023 Tirzepetide weight regain after discontinuation Source: Arrone, JAMA December 11, 2023 LINK There were three research publications on the anti-obesity GLP-1 drugs of interest to employers this last week